ZetaGen Therapeutics
Syracuse
About ZetaGen Therapeutics
ZetaGen Therapeutics is commercializing a small molecule-based osteoinductive platform technology to develop bone growth products that activate a novel molecular pathway. ZetaGen Therapeutics's goal is to halt cancer, reduce pain, and rebuild bones. The company's solution has the potential to revolutionize the treatment of bone-related injuries, operations, and diseases, resulting in better outcomes for both patients and doctors.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $27.3M
- Funding stage: Early Stage Venture
- Last round: Series B (Jan 2025)
- Website: zetagen.com
- Phone: 401-699-9402
Industries & Categories
Health Care, Medical Device, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/zetagen-therapeutics-82051 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.